← Leaderboards
Joel Erblich
Mount Sinai School Of Medicine Of Nyu
$4,800,720
Attributed
$5,258,723
Total exposure
18
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,000,198 · 20
By mechanism
U54$23,166,905 · 5
R25$916,007 · 1
R21$767,927 · 2
R34$751,190 · 1
K07$666,225 · 1
K22$468,660 · 1
Top collaborators
- Grace X Ma19 shared
- Jean-Pierre J Issa13 shared
- Olorunseun O Ogunwobi12 shared
- Jennifer S Ford11 shared
- Camille C Ragin7 shared
- Claudia Wultsch1 shared
- Lin Zhu1 shared
Most similar at Mount Sinai School Of Medicine Of Nyu
Same institution · by research overlap
- Paula J Busse$3,159,686
- Kurt P. Schulz$3,189,700
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelMalignant NeoplasmsMultidisciplinaryProgramsInstitutionCollaborationsFundingCancer Health DisparityMentorsResourcesEducationEvaluationCollegeCancer PreventionCommunitiesUniversitiesMemberInnovationInfrastructureResearch Project GrantsDoctor Of PhilosophyAreaCareer DevelopmentMortality
Grant awards (56)
TUFCCC/HC Regional Comprehensive Cancer Health Partnership$1,670,747
U54 · FY2025 · CA
TUFCCC/HC Regional Comprehensive Cancer Health Partnership$959,026
U54 · FY2025 · CA · contact PI
TUFCCC/HC Regional Comprehensive Cancer Health Disparities Partnership$226,595
U54 · FY2025 · CA · contact PI
(1/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparities Partnership$1,552,139
U54 · FY2024 · CA
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparities Partnership$980,462
U54 · FY2024 · CA · contact PI
STANDOUT in Behavioral Cancer Prevention and Control Research: Summer Training Accelerating and Nurturing the Development of Outstanding Undergraduate Trainees$304,669
R25 · FY2024 · CA · contact PI
TUFCCC/HC Regional Comprehensive Cancer Health Disparities Partnership$227,563
U54 · FY2024 · CA · contact PI
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparities Partnership$200,000
U54 · FY2024 · CA · contact PI
(1/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparities Partnership$1,763,950
U54 · FY2023 · CA
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparities Partnership$1,035,402
U54 · FY2023 · CA · contact PI
TUFCCC/HC Regional Comprehensive Cancer Health Disparities Partnership$311,530
U54 · FY2023 · CA · contact PI
STANDOUT in Behavioral Cancer Prevention and Control Research: Summer Training Accelerating and Nurturing the Development of Outstanding Undergraduate Trainees$304,818
R25 · FY2023 · CA · contact PI
Elucidating the Roles of Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease among Asian American Patients with Chronic Hepatitis B$189,986
U54 · FY2023 · CA
1/2 TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership$1,591,989
U54 · FY2022 · CA
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership$1,015,126
U54 · FY2022 · CA · contact PI
STANDOUT in Behavioral Cancer Prevention and Control Research: Summer Training Accelerating and Nurturing the Development of Outstanding Undergraduate Trainees$306,520
R25 · FY2022 · CA · contact PI
Administrative Core$127,803
U54 · FY2022 · CA · contact PI
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership$127,803
U54 · FY2022 · CA · contact PI
1/2 TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership$1,624,631
U54 · FY2021 · CA
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership$1,008,742
U54 · FY2021 · CA
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership$130,428
U54 · FY2021 · CA
1/2 TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership$1,657,271
U54 · FY2020 · CA
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership$895,790
U54 · FY2020 · CA
Full Research Project 2 Nicotine Dependence and Lung Cancer Genetics in African Americans$162,122
U54 · FY2020 · CA · contact PI
1/2 TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership$1,608,811
U54 · FY2019 · CA
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership$1,008,081
U54 · FY2019 · CA
Full Research Project 2 Nicotine Dependence and Lung Cancer Genetics in African Americans$177,555
U54 · FY2019 · CA · contact PI
1/2 TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership$1,671,024
U54 · FY2018 · CA
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership$1,050,067
U54 · FY2018 · CA
Full Research Project 2 Nicotine Dependence and Lung Cancer Genetics in African Americans$192,262
U54 · FY2018 · CA · contact PI
A Combination of Scheduled Reduced Smoking with Varenicline to Enhance Cessation$254,250
R34 · FY2014 · DA · contact PI
Behavioral Dysregulation: Impact on Alcohol Cue-Reactivity and Demand for Alcohol$213,339
R21 · FY2014 · AA · contact PI
A Combination of Scheduled Reduced Smoking with Varenicline to Enhance Cessation$244,080
R34 · FY2013 · DA · contact PI
Behavioral Dysregulation: Impact on Alcohol Cue-Reactivity and Demand for Alcohol$181,688
R21 · FY2013 · AA · contact PI
A Combination of Scheduled Reduced Smoking with Varenicline to Enhance Cessation$252,860
R34 · FY2012 · DA · contact PI
Stress-Induced Craving and Smoking Cessation: Effects of Dopamine-related Genes$156,220
K22 · FY2009 · CA · contact PI
STRESS-INDUCED CRAVING AND SMOKING CESSATION:EFFECTS OF DOPAMINE-RELATED GENES$3,181
M01 · FY2009 · RR · contact PI
DOPAMINE GENOTYPES, EXPERIMENTALLY-INDUCED CRAVING, & FEMALE SMOKING CESSATION$2,692
M01 · FY2009 · RR · contact PI
A PILOT FMRI STUDY OF CUE-INDUCED CIGARETTE CRAVING$490
M01 · FY2009 · RR · contact PI
Dopamine Genotypes, Experimentally-induced Craving, & Cessation in Female Smokers$203,400
R21 · FY2008 · CA · contact PI
Stress-Induced Craving and Smoking Cessation: Effects of Dopamine-related Genes$156,220
K22 · FY2008 · CA · contact PI
A PILOT FMRI STUDY OF CUE-INDUCED CIGARETTE CRAVING$15,980
M01 · FY2008 · RR · contact PI
STRESS-INDUCED CRAVING AND SMOKING CESSATION:EFFECTS OF DOPAMINE-RELATED GENES$6,279
M01 · FY2008 · RR · contact PI
DOPAMINE GENOTYPES, EXPERIMENTALLY-INDUCED CRAVING & CESSATION IN FEMALE SMOKERS$4,566
M01 · FY2008 · RR · contact PI
Dopamine Genotypes, Experimentally-induced Craving, & Cessation in Female Smokers$169,500
R21 · FY2007 · CA · contact PI
Stress-Induced Craving and Smoking Cessation: Effects of Dopamine-related Genes$156,220
K22 · FY2007 · CA · contact PI
A PILOT FMRI STUDY OF CUE-INDUCED CIGARETTE CRAVING$3,040
M01 · FY2007 · RR · contact PI
Dopamine Polymorphisms and Smoking Cue-Reactivity$133,245
K07 · FY2006 · CA · contact PI
Dopamine Polymorphisms and Smoking Cue-Reactivity$133,245
K07 · FY2005 · CA
POLYMORPHISMS OF THE DOPAMINE TRANSPORTER GENE AND REACTIVITY TO SMOKING CUES$22,951
M01 · FY2005 · RR
Dopamine Polymorphisms and Smoking Cue-Reactivity$133,245
K07 · FY2004 · CA
Polymorphisms of the Dopamine Transporter Gene and Reactivity to Smoking Cues$35,300
M01 · FY2004 · RR
Dopamine Polymorphisms and Smoking Cue-Reactivity$133,245
K07 · FY2003 · CA
Dopamine Polymorphisms and Smoking Cue-Reactivity$133,245
K07 · FY2002 · CA
FAMILY HISTORY OF SMOKING AND REACTIVITY TO SMOKING CUES$84,750
R03 · FY2001 · CA
FAMILY HISTORY OF SMOKING AND REACTIVITY TO SMOKING CUES$84,055
R03 · FY2000 · CA